Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.40 | - | - |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €3.84 | - | - |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Novan Inc | 0 | 24 | 0 | 2 | €0.001 | - | - |
| ViewRay Inc | 0 | 3 | 0 | 0 | €0.025 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| Organovo Holdings Inc. | 0 | 6 | 0 | 1 | €0.89 | - | - |
| Trupanion Inc. | 0 | 2 | 0 | 1 | €20.89 | - | - |
| Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.90 | - | - |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.56 | - | - |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €0.96 | - | - |
| T2 Biosystems Inc. | 0 | 12 | 0 | 0 | €0.16 | - | - |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.33 | €0.000 | -100.000% |
| Medigene AG | 0 | 2 | 0 | 0 | €1.48 | €1.00 | -32.203% |
| Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 2 | €1.04 | €2.00 | 93.143% |
| Sangamo Therapeutics Inc. | 11 | 13 | 0 | 1 | €0.49 | €2.79 | 469.370% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.59 | €3.00 | 409.165% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.06 | €3.00 | 45.773% |
| Karyopharm Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.08 | €3.65 | 238.701% |
| Avinger Inc. | 2 | 7 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Tonix Pharmaceuticals Holding Corp. | 2 | 16 | 0 | 2 | €2.82 | €5.03 | 78.387% |
| Gritstone Oncology Inc | 2 | 2 | 0 | 0 | €0.89 | €6.53 | 632.997% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.26 | €7.00 | 209.735% |
| Agenus Inc. | 2 | 2 | 0 | 0 | €0.41 | €7.30 | 1664.911% |